Frankfurt - Delayed Quote EUR

Avid Bioservices, Inc. (TEHP.F)

Compare
11.70 +0.20 (+1.74%)
At close: November 22 at 8:05 AM GMT+1
Loading Chart for TEHP.F
DELL
  • Previous Close 11.50
  • Open 11.70
  • Bid 11.70 x --
  • Ask 11.80 x --
  • Day's Range 11.70 - 11.70
  • 52 Week Range 4.12 - 11.70
  • Volume 0
  • Avg. Volume 0
  • Market Cap (intraday) 546.127M
  • Beta (5Y Monthly) 1.40
  • PE Ratio (TTM) 79.59
  • EPS (TTM) 0.15
  • Earnings Date Dec 5, 2024 - Dec 9, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Avid Bioservices, Inc. operates as a contract development and manufacturing organization for the biotechnology and biopharmaceutical industries in the United States. It provides process development and current good manufacturing practice clinical and commercial manufacturing services of biologics, including clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, regulatory submission and support, upstream and downstream development and optimization, analytical methods development, cell line development, testing, and characterization services. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is based in Tustin, California.

www.avidbio.com

371

Full Time Employees

April 30

Fiscal Year Ends

--

Sector

--

Industry

Recent News: TEHP.F

View More

Performance Overview: TEHP.F

Trailing total returns as of 11/23/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

TEHP.F
91.80%
MSCI WORLD
18.83%

1-Year Return

TEHP.F
134.00%
MSCI WORLD
25.33%

3-Year Return

TEHP.F
61.00%
MSCI WORLD
17.63%

5-Year Return

TEHP.F
154.35%
MSCI WORLD
65.62%

Compare To: TEHP.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: TEHP.F

View More

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -101.27%

  • Return on Assets (ttm)

    -3.05%

  • Return on Equity (ttm)

    -115.84%

  • Revenue (ttm)

    142.36M

  • Net Income Avi to Common (ttm)

    -144.16M

  • Diluted EPS (ttm)

    0.15

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    36.78M

  • Total Debt/Equity (mrq)

    353.77%

  • Levered Free Cash Flow (ttm)

    -201.62k

Research Analysis: TEHP.F

View More

Company Insights: TEHP.F

Research Reports: TEHP.F

View More